Top Markets
Coin of the day
LB Pharmaceuticals Inc Common Stock LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX
Rangering i aksjer #8002
This biopharmaceutical firm is currently in the clinical development stage,... This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
Aksjekurs
$48.45
Markedsverdi
$1.39B
Endring (1 dag)
1.16%
Endring (1 år)
-
Land
US
Handel LB Pharmaceuticals Inc Common Stock (LBRX)

Kategori

Utbyttehistorikk for LB Pharmaceuticals Inc Common Stock (LBRX)
LB Pharmaceuticals Inc Common Stock (aksjesymbol: LBRX) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for LB Pharmaceuticals Inc Common Stock (LBRX) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter
Selskap Antall utbyttebetalinger Land
0.00%
US
0.00%
NL
64.00%
AU
0.00%
US
0.00%
CH